Atossa Genetics (ATOS) IPO Trades Lower
Tweet
Share
E-mailGet Alerts ATOS Hot Sheet
Up)Join SI Premium – FREE
The IPO for Atossa Genetics (NASDAQ: ATOS) is trading at $4.70 per share after pricing 800,000 shares at $5.
Dawson James Securities, Inc. is the sole book-running manager for this offering.
Atossa Genetics, Inc., The Breast Health Company, is based in Seattle, Washington, and is focused on the prevention of breast cancer through the commercialization of diagnostic medical devices and tests that can detect precursors to breast cancer, and through research and development that will permit it to commercialize treatments for pre-cancerous lesions.
Dawson James Securities, Inc. is the sole book-running manager for this offering.
Atossa Genetics, Inc., The Breast Health Company, is based in Seattle, Washington, and is focused on the prevention of breast cancer through the commercialization of diagnostic medical devices and tests that can detect precursors to breast cancer, and through research and development that will permit it to commercialize treatments for pre-cancerous lesions.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tungray Technologies (TRSG) Closes $5M IPO
- Ibotta (IBTA) starts trading at $118, price IPO at $88
- Atossa Therapeutics (ATOS) and Quantum Leap Healthcare Announce I-SPY 2 Trial to Evaluate (Z)-Endoxifen in Combination with Abemaciclib
Create E-mail Alert Related Categories
IPOsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
